Stay updated on Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Sign up to get notified when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a technical/UI update rather than a change to the study record.
    Difference
    0.1%
    Check dated 2026-04-24T05:54:03.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.0 to v3.5.2.
    Difference
    0.2%
    Check dated 2026-04-17T02:33:30.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The new screenshot shows updates to the page layout and navigation elements. There are no changes to the core study data (eligibility criteria, endpoints, or study descriptions).
    Difference
    0.1%
    Check dated 2026-04-09T21:31:59.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    No substantive content changes detected; the two screenshots show the same study details and page structure. Any observed differences appear to be visual/UI adjustments only.
    Difference
    0.1%
    Check dated 2026-04-02T15:23:55.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    No additions or deletions were detected between the two screenshots; the page content and structure appear unchanged.
    Difference
    0.1%
    Check dated 2026-03-26T11:24:15.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Site revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:13:00.000Z thumbnail image

Stay in the know with updates to Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase II Nivolumab Plus Ipilimumab in Sarcoma & Endometrial Clinical Trial page.